Calcitonin

Drug Index

2JXZ,%%s1LS7IdentifiersAliasesCALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC, PCT, calcitonin related polypeptide alpha, CGRP-alphaExternal IDsOMIM: 114130 HomoloGene: 88401 GeneCards: CALCA Gene location (Human)Chr.Chromosome 11 (human)[1]Band11p15.2Start14,966,668 bp[1]End14,972,351 bp[1]RNA expression patternBgeeTop expressed in spinal ganglia trigeminal ganglion kidney quadriceps femoris muscle vastus lateralis muscle cerebellar vermis islet of ...

Calcitonin Salmon Recombinant

2JXZ,%%s1LS7IdentifiersAliasesCALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC, PCT, calcitonin related polypeptide alpha, CGRP-alphaExternal IDsOMIM: 114130 HomoloGene: 88401 GeneCards: CALCA Gene location (Human)Chr.Chromosome 11 (human)[1]Band11p15.2Start14,966,668 bp[1]End14,972,351 bp[1]RNA expression patternBgeeTop expressed in spinal ganglia trigeminal ganglion kidney quadriceps femoris muscle vastus lateralis muscle cerebellar vermis islet of ...

Has anyone experienced any side effects from Calcitonin? I have severe headaches and am susceptible to sinus infections. I also have lower back and joint pain. ## Hello Sanjoe, Sorry to hear that you are experiencing so many difficulties with your medication. I have pulled up some information for you. According to the National Institute of Health these are the following adverse reactions associated with taking Calcitonin-Salmon nasal spray. All information listed is in reference to the Apotex Corp generic (NDC: 60505-0823) - Back Pain - Headache - Nasal Crusts - Dryness - Redness Or Erythema - Nasal Sores - Irritation - Itching - Thick Feeling - Soreness - Pallor - Infection - Stenosis - Runny/blocked - Small Wound - Bleeding Wound - Tenderness - Uncomfortable Feeling And Sore Across B...

1 REPLY

IT IS A SPRAY TO BE TAKEN THROUGH NOSTRILS FOR THE DEFICIENCY OF CALCIUM.IT'S TRADE NAME IS OSTOSPRAY.IT IS GIVEN FOR KNEE PAIN FOR LAST MANY YEARS (AGE-62) LET ME KNOW SHOULD IT BE INHALED ## NO, just spray it. don't tilt head back it'll run down your throat.

1 REPLY

Erenumab-aooe

Erenumab, sold under the brand name Aimovig, is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine.[2][3][4] Erenumab was approved in May 2018 and was the first of a group of four CGRPR antagonists to be approved by the U.S. Food and Drug Administration (FDA) that year. It is a form of monoclonal antibody therapy in which antibodies are used to block the receptors for the protein CGRP, ...

Calcitonin

2JXZ,%%s1LS7IdentifiersAliasesCALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC, PCT, calcitonin related polypeptide alpha, CGRP-alphaExternal IDsOMIM: 114130 HomoloGene: 88401 GeneCards: CALCA Gene location (Human)Chr.Chromosome 11 (human)[1]Band11p15.2Start14,966,668 bp[1]End14,972,351 bp[1]RNA expression patternBgeeTop expressed in spinal ganglia trigeminal ganglion kidney quadriceps femoris muscle vastus lateralis muscle cerebellar vermis islet of ...

Calcitonin Salmon Recombinant

2JXZ,%%s1LS7IdentifiersAliasesCALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC, PCT, calcitonin related polypeptide alpha, CGRP-alphaExternal IDsOMIM: 114130 HomoloGene: 88401 GeneCards: CALCA Gene location (Human)Chr.Chromosome 11 (human)[1]Band11p15.2Start14,966,668 bp[1]End14,972,351 bp[1]RNA expression patternBgeeTop expressed in spinal ganglia trigeminal ganglion kidney quadriceps femoris muscle vastus lateralis muscle cerebellar vermis islet of ...

Drug Index

Erenumab, sold under the brand name Aimovig, is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine.[2][3][4] Erenumab was approved in May 2018 and was the first of a group of four CGRPR antagonists to be approved by the U.S. Food and Drug Administration (FDA) that year. It is a form of monoclonal antibody therapy in which antibodies are used to block the receptors for the protein CGRP, ...

Calcitonin

2JXZ,%%s1LS7IdentifiersAliasesCALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC, PCT, calcitonin related polypeptide alpha, CGRP-alphaExternal IDsOMIM: 114130 HomoloGene: 88401 GeneCards: CALCA Gene location (Human)Chr.Chromosome 11 (human)[1]Band11p15.2Start14,966,668 bp[1]End14,972,351 bp[1]RNA expression patternBgeeTop expressed in spinal ganglia trigeminal ganglion kidney quadriceps femoris muscle vastus lateralis muscle cerebellar vermis islet of ...

Atogepant

Atogepant, sold under the brand name Qulipta, is a medication used to treat migraines. It is a gepant, an orally active calcitonin gene-related peptide receptor (CGRPR) antagonist.[1][2] It was approved for medical use in the United States in September 2021.[1][3] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0...

Drug Index

Atogepant, sold under the brand name Qulipta, is a medication used to treat migraines. It is a gepant, an orally active calcitonin gene-related peptide receptor (CGRPR) antagonist.[1][2] It was approved for medical use in the United States in September 2021.[1][3] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0...

What's the best way to administer Ostospray to ensure maximum absorption? ## Otospray contains the active ingredient Calcitonin and is most commonly used to help protect against bone mineral loss. As to how much is absorbed into the body, I haven't found any information on that. However, with most medications, it is only a small fraction of what is actually in any given dosage. Does anyone else have any information to add?

1 REPLY

Eptinezumab-jjmr

Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults.[3] It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta.[3][4][5] It is administered by intravenous infusion.[3] Eptinezumab was approved for medical use in the United States in February 2020.[6][7] Contents 1 History 2 ...

Drug Index

Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults.[3] It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta.[3][4][5] It is administered by intravenous infusion.[3] Eptinezumab was approved for medical use in the United States in February 2020.[6][7] Contents 1 History 2 ...

Ubrogepant

Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults.[1][2] It is not indicated for the preventive treatment of migraine.[3] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.[4][5] It is the first drug in this class approved for the acute treat...

Drug Index

Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults.[1][2] It is not indicated for the preventive treatment of migraine.[3] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.[4][5] It is the first drug in this class approved for the acute treat...

Fremanezumab-vfrm

Fremanezumab, sold under the brand name Ajovy, is a medication used to prevent migraines in adults.[6][4] It is given by injection under the skin.[6][4] The most common side effect is pain and redness at the site of injection.[6] Other side effects include allergic reactions.[6] It is in the calcitonin gene-related peptide antagonist class of medications.[6] It was approved for medi...

Drug Index

Fremanezumab, sold under the brand name Ajovy, is a medication used to prevent migraines in adults.[6][4] It is given by injection under the skin.[6][4] The most common side effect is pain and redness at the site of injection.[6] Other side effects include allergic reactions.[6] It is in the calcitonin gene-related peptide antagonist class of medications.[6] It was approved for medi...

Galcanezumab-gnlm

Galcanezumab, sold under the brand name Emgality, is a humanized monoclonal antibody used for the prevention of migraine.[1][2] It is also used for cluster headaches.[3] Common side effects include pain or redness at the site of injection.[3][4] Other side effects may include hypersensitivity reactions.[3] A substance called calcitonin gene-related peptide (CGRP) has been shown to be involved in th...

Drug Index

Galcanezumab, sold under the brand name Emgality, is a humanized monoclonal antibody used for the prevention of migraine.[1][2] It is also used for cluster headaches.[3] Common side effects include pain or redness at the site of injection.[3][4] Other side effects may include hypersensitivity reactions.[3] A substance called calcitonin gene-related peptide (CGRP) has been shown to be involved in th...